We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 460.00
Bid: 450.00
Ask: 470.00
Change: -5.00 (-1.08%)
Spread: 20.00 (4.444%)
Open: 465.00
High: 465.00
Low: 460.00
Prev. Close: 465.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Issue of Equity

22 Jul 2020 16:43

RNS Number : 8056T
Tristel PLC
22 July 2020

Tristel plc

("Tristel" or the "Company")

Director/PDMR Shareholding and Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of share options by certain directors it has issued and allotted 878,629 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). To meet the exercise cost and associated tax liabilities, the directors have subsequently sold 548,629 Ordinary Shares at a price of 404.2 pence per share. In addition, Paul Barnes, Non-Executive Director, has sold 336,095 Ordinary Shares at a price of 404.2 pence per share.

In summary:

Director

Total number of share options exercised

Number of Ordinary Shares sold

Resultant Shareholding

Percentage of the Company's issued share capital held

Remaining number of options held

Paul Swinney

487,097

320,431

643,095

1.4%

166,666

Liz Dixon

331,532

198,198

178,334

0.4%

133,334

Paul Barnes

30,000

351,095

30,000

0.1%

15,000

David Orr

30,000

15,000

43,191

0.1%

15,000

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 29 July 2020.

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares of the Company. Following the above exercise of options, the Company's issued share capital consists of 46,175,162Ordinary Shares. Accordingly, the figure of 46,175,162may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780 or聽tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash (Corporate Finance)

Giles Rolls (Corporate Finance)

Alice Lane (ECM)

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Swinney

2.

Reason for the Notification.

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

487,097

Sale Price(s)

Volume(s)

404.2p

320,431

d)

Aggregated information:

Aggregated volume

Price

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Liz Dixon

2.

Reason for the Notification.

a)

Position/status

Finance Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

331,532

Sale Price(s)

Volume(s)

404.2p

198,198

d)

Aggregated information:

Aggregated volume

Price

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Barnes

2.

Reason for the Notification.

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

30,000

Sale Price(s)

Volume(s)

404.2p

351,095

d)

Aggregated information:

Aggregated volume

Price

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Orr

2.

Reason for the Notification.

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over Ordinary Shares

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Exercise of Options

Sale of Ordinary shares

c)

Price(s) and volume(s)

Exercise Price

Volume(s)

1p

30,000

Sale Price(s)

Volume(s)

404.2p

15,000

d)

Aggregated information:

Aggregated volume

Price

As above

e)

Date of the transaction

22 July 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHPPUUCMUPUGAP
Date   Source Headline
5th Nov 20188:35 amRNSIssue of Equity
17th Oct 20187:00 amRNSFinal Results
13th Sep 20187:00 amRNSNotice of Results
24th Aug 20187:00 amRNSIssue of Equity
23rd Aug 20187:00 amRNSIssue of Equity
19th Jul 20184:21 pmRNSHolding(s) in Company
19th Jul 20183:55 pmRNSHolding(s) in Company
16th Jul 20185:49 pmRNSResult of secondary placing
16th Jul 20181:53 pmRNSProposed secondary placing of Ordinary Shares
13th Jul 20187:00 amRNSTrading update & Notice of results
12th Jun 20184:39 pmRNSIssue of Equity
11th Jun 20182:37 pmRNSDirector/PDMR Shareholding
8th Jun 20187:00 amRNSShareholder Open Day
7th Jun 20188:15 amRNSIssue of Equity
1st Jun 20183:50 pmRNSDirector/PDMR Shareholdings
15th May 20188:14 amRNSHolding(s) in Company
11th May 20185:45 pmRNSDirector/PDMR Shareholding
10th May 20188:26 amRNSHolding(s) in Company
8th May 20189:51 amRNSIssue of Equity
2nd May 20184:55 pmRNSDirector/PDMR Dealing and Issue of Equity
23rd Apr 20187:00 amRNSEPA approval received
13th Apr 20182:55 pmRNSIssue of Equity
27th Mar 20188:19 amRNSIssue of Equity
26th Mar 20187:00 amRNSCommercial collaboration with Parker Laboratories
8th Mar 201810:58 amRNSIssue of Equity
20th Feb 20187:00 amRNSHalf-year Report
8th Feb 20182:19 pmRNSHolding(s) in Company
26th Jan 20187:00 amRNSIssue of Equity
24th Jan 20187:00 amRNSStudy shows comparable efficacy of Tristel Wipes
17th Jan 20187:00 amRNSInvestor results presentation
12th Dec 20172:57 pmRNSResult of AGM
12th Dec 20177:00 amRNSAGM Statement & notice of results
27th Nov 201710:35 amRNSIssue of Equity
23rd Nov 20173:24 pmRNSClarification of AGM timing
14th Nov 201710:34 amRNSIssue of Equity
2nd Nov 20177:00 amRNSDirectors dealing/grant of options
23rd Oct 20174:41 pmRNSIssue of Equity
19th Oct 20177:01 amRNSDirector Appointment
19th Oct 20177:00 amRNSFinal Results
3rd Oct 20177:00 amRNSTiming of EPA approval
19th Sep 20177:00 amRNSInvestor results presentation
18th Sep 20171:44 pmRNSIssue of Equity
22nd Aug 201712:08 pmRNSIssue of Equity
18th Aug 20171:31 pmRNSDirector/PDMR Dealing - replacement
17th Aug 20177:00 amRNSDirector/PDMR Dealing
7th Aug 20172:29 pmRNSIssue of Equity
24th Jul 20179:46 amRNSIssue of Equity
19th Jul 20177:00 amRNSTrading update & Notice of results
5th Jul 20177:00 amRNSIssue of Equity
3rd Jul 20171:59 pmRNSStrategic investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.